SEATTLE, May 1 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX) has
scheduled presentations at the following conferences in May 2001. The
conferences, their respective dates and locations are as follows:
-- Ragen MacKenzie 20th Annual Investment Conference
Tuesday, May 1, 2001
Bellevue, Washington - Meydenbauer Center
-- NASDAQ Life Sciences Forum
Tuesday, May 1, 2001
London, England
-- NASDAQ Life Sciences Forum
Thursday, May 3, 2001
Zurich, Switzerland
-- Deutsche Banc Alex Brown 26th Annual Healthcare Conference
Wednesday, May 9, 2001
Baltimore, Maryland - Baltimore Marriott Waterfront
For information about available webcasts and replays, visit the Investor
Relations page at the Immunex website at http://www.immunex.com/investor_fs3.html.
Immunex Corporation is a leading biopharmaceutical company dedicated to
improving lives through immune system science innovations.
NOTE: Except for the historical information contained herein, this news
release contains forward-looking statements that involve substantial risks and
uncertainties. Among the factors that could cause actual results or timelines
to differ materially are risks associated with research and clinical
development, regulatory approvals, our supply capabilities and reliance on
third-party manufacturers, product commercialization, competition, litigation
and other risk factors listed from time to time in reports filed by Immunex
with the SEC, including but not limited to risks described under the caption
"Important Factors That May Affect Our Business, Our Results of Operations and
Our Stock Price" within our most recently filed Form 10-K. The
forward-looking statements contained in this news release represent our
judgment as of the date of this release. Immunex undertakes no obligation to
publicly update any forward-looking statements. An electronic version of this
news release -- as well as additional information about Immunex of interest to
investors, customers, future employees and patients -- is available on the
Immunex home page at http://www.immunex.com.
SOURCE Immunex Corporation
 back to top
Related links:
http://www.immunex.com
Company News On-Call:
http://www.prnewswire.com/comp/434644.html or fax,
800-758-5804, ext. 434644
CONTACT:
media, Robin Shapiro, 206-389-4040, or
investors, Mark Leahy, 206-389-4040, both of Immunex Corporation
|
